Weekly Colloquium on Problems in the Biology of Complex Diseases

Cancer Center
Cardiovascular Research Program
College of Pharmacy
OPA (Office of Public Affairs)
Research Administration - UAHS
UAHS
College of Medicine - Tucson
Aging Center
Arthritis Center
Department of Family and Community Medicine
Department of Immunobiology
Department of Medical Imaging
Department of Medicine
Department of Obstetrics and Gynecology
Department of Otolaryngology
Department of Pharmacology
Department of Physiology
Sarver Heart Center
February 15, 2019 - 9:00am to 11:00am

Brought to you by the Arizona Center for the Biology of Complex Diseases (ABCD) at the University of Arizona:

TOPIC“Cancer Genetics”
SPEAKER: Jianfeng Xu, MD, DrPH — Vice President of Translational Research, the Ellrodt-Schweighauser Family Chair of Cancer Genomic Research and Director of the Program for Personalized Cancer Care (PPCC) within the Mark R. Neaman Center for Personalized Medicine at NorthShore University HealthSystem
WHEN: Friday, Feb. 15, 2018 | 9-11 a.m.

Weekly Colloquium, Spring 2019 – Problems in the Biology of Complex Diseases
(CMM, MCB, GENE, IMB, PCOL 595H)
Fridays, 9-11 a.m., Keating/BIO5 Room 103, Jan. 11-April 26 (except for March 1, 9-11 a.m., Keating/BIO5 Room 247)

SPEAKERS SCHEDULE: Click here [PDF] for a printable schedule for the entire series.

About the Speaker
Dr. Xu joined NorthShore in the fall of 2014. His previous position was at Wake Forest University Medical Center, where he was Professor of Genomics and Personalized Medicine Research, Epidemiology, Cancer Biology and Urology, as well as the Director of the Center for Cancer Genomics. He is an internationally known genetic epidemiologist and genomic translational researcher, and has been working on genetic studies of cancer and other diseases for over 20 years. Dr. Xu has received multiple grants from the National Institutes of Health and has published over 300 papers in such journals as the New England Journal of Medicine and Nature Genetics. His primary research interests are 1) discovery of associations for cancer risk and progression with inherited genetic variations as well as somatic genetic and epigenetic changes in tumors, and 2) application of genetic research findings for risk prediction, and genomic-targeted prevention, diagnosis, and treatment of cancer. Dr. Xu received his medical training at Shanghai Medical University and genetic epidemiology training at Johns Hopkins School of Public Health. 

Learn more about this lecture series.

For further information, contact ABCD Director Donata Vercelli, MD, colloquium organizer: donata@email.arizona.edu 

Event Location: 

University of Arizona BIO5 Institute, Room 103
Thomas W. Keating Bioresearch Building
1657 E. Helen St.
Tucson, AZ 85721